510(k) device
AtriClip FLEX-Mini LAA Exclusion System (ACHM)
AtriCure, Inc. · Left Atrial Appendage Clip, Implantable (PZX, Class II) · First FDA decision Jul 29, 2024, newest Jul 29, 2024Atrial fibrillationStroke prevention in atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "AtriClip FLEX-Mini LAA"
MAUDE reports
2
Brand "AtriClip FLEX-Mini LAA", since 2015
PubMed studies
0
Mentioning "AtriClip FLEX-Mini LAA"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AtriClip FLEX-Mini LAA Exclusion System (ACHM)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K234125 · Decided Jul 29, 2024 · 214 days after receipt
Device type: Left Atrial Appendage Clip, Implantable (PZX) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "AtriClip FLEX-Mini LAA", any status and sponsor, newest update first.
No registered device study names "AtriClip FLEX-Mini LAA".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AtriClip FLEX-Mini LAA", and for the whole product code for context.
This brand
2 reports: 0 malfunction, 2 injury, 0 death
Whole product code PZX
145 reports: 50 malfunction, 87 injury, 7 death
Newest reports for this brand
3011706110-2026-00024 · Received May 14, 2026 · Event dated Apr 16, 2026
Device type: Left Atrial Appendage Clip, Implantable (PZX)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding
3011706110-2025-00010 · Received Jan 29, 2025 · Event dated Jan 5, 2025
Device type: Left Atrial Appendage Clip, Implantable (PZX)
Device problem as coded: Use of Device Problem
Patient problem as coded: Cardiac Perforation
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "AtriClip FLEX-Mini LAA"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PZX.
- AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (LAA0)AtriCure, Inc. · 510(k) 2023
- LAA Exclusion SystemSyntheon, LLC · 510(k) 2023
- ACHM30 AtriClip FLEX-Mini LAA Exclusion SystemAtriCure, Inc. · 510(k) 2026
- ECLIPTIS Left Atrial Appendage Exclusion System (ECS135)Edwards Lifesciences · 510(k) 2026
- ATLAAS (Atraumatic Left Atrial Appendage System) (AD)Genesee Biomedical, Inc. · 510(k) 2026
- AtriClip PRO-Mini LAA Exclusion System (PROM)AtriCure, Inc. · 510(k) 2025
- ArtiClip LAA Exclusion SystemAtriCure, Inc. · 510(k) 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.